Home > Healthcare IT > Global Depression Treatment Device Market Size, Share, Trends, Global Growth & Forecast
Straits Research

Depression Treatment Device Market

Depression Treatment Device Market: Information by Product Type (Light Therapies, Helmet Therapies), Depression Type (Postpartum Depression, Psychotic Depression), End User), and Region — Forecast till 2026

Table of Content Download Sample

Market Overview

Depression is characterized by multiple mental health challenges that involve a lack of positivity, suicidal thoughts, insomnia, anxiety, loss of appetite, and sadness. Depression is caused by a combination of biological, genetic, environmental, and psychological factors. Globally, the prevalence of depression is increasing at an alarming rate. About 300 million people of all ages suffered from depression and the suicide rate rose to about 8,00,000 individuals in 2018. As per the CDC, the prevalence of depression is about 1 in every 6 adults. In the U.S. alone, over 16 million people are suffering from depression. As per the National Health and Nutrition Examination study, around 8.1% of Americans aged 20 and above experienced depression in a given 2-week period between 2013–2016. Apart from this, around 20–25% of people suffering from diabetes, cancer, stroke, and myocardial infarction are likely to develop depression. Also, around 10%–25% of women and 5%–12% of men are suffering from depression across the globe, which is further grabbing the attention of leading market players in the production of novel approaches to treat depression in the most efficient way. The governments and leading players are heavily investing in the manufacturing of depression treatment devices to control the prevalence of depression across the globe.

Traditionally, brain stimulation therapies were performed by physicians in hospitals, home care settings, clinics, and rehabilitation centers. However, depression devices have paved its way to becoming a breakthrough technology for the analysis and treatment of depression in the comfort of the home. Recently, Alpha-stim developed ALPHA-STIM CES for the effective way treatment of depression. It is a lightweight, FDA-released prescription device that uses Cranial Electrotherapy Stimulation (CES) to alleviate depression in the comfort of the home.

Market Snapshot

market snapshot
Base Year
: 2017
Study Period
: 2016-2026
CAGR
: 3.3 %
Fastest Growing Market
: North America
Largest Market
: Asia- Pacific
Market Size
: 17770
Get more information on this report Download Sample Report

Segmental Analysis

Helmet Therapy to Gain Pace over The Years

Helmet therapy is grabbing one of the highest shares in the depression treatment market. The people suffering from depression fail to respond to medication or psychological counseling, which is further boosting the need for helmet therapy as it delivers electromagnetic impulses to the brain and aids in treating depression in a more efficient way. The new device targets malfunctioning blood cells in the brain. To date, around 65 patients have been treated with helmet therapy.

Home Care Settings to Dominate the Market

The home care setting segment is dominating the depression treatment devices market. It is gaining popularity among patients as it offers better treatment in the comfort of the home. It also provides flexibility to limit care to over 2-3 days a week. In fact, after a single treatment, the majority of the patients have experienced significant relief, which is further driving the segment growth.

Regional Analysis

Regionally, the depression treatment device market is segmented into the Americas, Europe, Asia Pacific, and The Middle East and Africa (MEA)

Americas to Dominate the Market

North America is holding one of the highest shares in the depression treatment devices market on account of rising stress in daily lives, which is subsequently increasing the prevalence of depression. In the U.S. alone, around 3.2 million people aged 12–17 have suffered from depression once in their lifetime. To attend to the dire situation, the leading players in the market are arduously working to develop an optimum solution and are heavily investing in R&D activities for the same, which is further driving the market growth.  

Europe to Grab the Second Largest Share in the Global Depression Treatment Devices Market

Europe is second in the depression treatment device market. This can be attributed to the increasing prevalence of depression and other mental disorders in the region. As per the WHO, in 2015, around 110 million people suffered from depression. However, the region is backed with the presence of leading players that are actively working to develop optimum depression treatment devices.

The Asia Pacific to Take a Strong Lead in the Market

The Asia Pacific is gaining momentum in the depression treatment devices market. As per the WHO, in India, nearly 6.5% of Indians are suffering from serious mental disorders. Similarly, China is housing a huge population suffering from depression and anxiety patients, and the number is projected to increase in the years to come as the country only spends about 2.35% of its budget on mental health. However, the region is backed by the presence of leading players that are engaging in a number of mergers and acquisitions to develop technologically advanced devices.

The Middle East and Africa to Emerge in the Market

The Middle East is emerging in the depression treatment device market. This can be attributed to the growing prevalence of depression, rising awareness regarding mental issues and its treatment, and increasing healthcare expenditure. Additionally, the governments in the region are actively working to spread awareness regarding depression and its effects on life. Whereas, Africa is expected to witness slow growth due to lack of availability of qualified mental health professionals, lack of infrastructure and funding, and lack of treatment guidelines.

Depression Treatment Device Market Regional Analysis
Regional Growth Insights Download Free Sample

Top Key Players of Depression Treatment Device Market

The global depression treatment device market is fragmented in nature. Several large and small-scale players are focusing on price, brand, and new product development to expand their consumer base.

Some of the key players are engaging in acquisitions, collaborations, and partnerships to gain a competitive edge. 

  1. San Diego
  2. California. Apart from this
  3. MagVenture A/S
  4. Electromedical Products International INC.
  5. Brainsway Ltd
  6. Neuro-Fitness LLC
  7. Boston Scientific Corporation

Report Scope

Report Metric Details
CAGR 3.3%
Forecast Period 2023-2031
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered
  1. By Product Type
    1. Light Therapy
    2. Stimulation Therapies
    3. Electro Stimulator Devices
    4. Helmet Therapies
    5. Others
  2. By End-User
    1. Hospitals
    2. Home Care Settings
    3. Long Term Centers
    4. Outpatient Settings
Geographies Covered
  • North America
  • Europe
  • APAC
  • Middle East and Africa
  • LATAM

Depression Treatment Device Market Segmentation

By Product Type

  • Light Therapy
  • Stimulation Therapies
  • Electro Stimulator Devices
  • Helmet Therapies
  • Others

By End-User

  • Hospitals
  • Home Care Settings
  • Long Term Centers
  • Outpatient Settings

By Regions 

  • Americas

    • North America
    • South America
  • Europe

    • Western Europe
    • Eastern Europe
  • Asia-Pacific

    • MEA
    • The Middle East
  • Africa

Frequently Asked Questions (FAQs)

What is the estimated growth rate (CAGR) of the Depression Treatment Device Market?
Depression Treatment Device Market size will grow at approx. CAGR of 3.3% during the forecast period.
Some of the top prominent players in Depression Treatment Device Market are, San Diego, California. Apart from this, MagVenture A/S, Electromedical Products International INC., Brainsway Ltd, Neuro-Fitness LLC, Boston Scientific Corporation, etc.
In the Depression Treatment Device Market, Asia- Pacific has established itself as the market leader with a significant market share.
The region with the most rapid expansion in the Depression Treatment Device Market is North America.
The global Depression Treatment Device Market report is segmented as follows: By Product Type, By End-User
Price Starts From
USD 995

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report
Want to learn more about recent trends and data ?
They Already Trust Us :
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Johnson & Johnson
Need Assistance?
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track sales in the global and country-specific Market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Report Snapshot
Looking For Custom Report ?
Check Our License Options :

As featured on :

clients
Trusted by Fortune 500
Over 30000+ subscribers